Safety Notices

From time to time notices relating to the safety and/or quality of medicinal products are published by the Health Products Regulatory Authority

These notices are classified under several priority related categories and may relate to human and veterinary medicines, or medical devices.   

The issues covered by these notices will range from quality defect information and medicinal product safety information through to updated information on the appropriate usage of medicines or devices.

Notices are categorised in accordance with their importance at time of publication.

The four notice categories are outlined as follows:

  • Advisory  -  Routine safety information            
  • Warning  -  Urgent safety information
  • Recall  -  Urgent safety information relating to a product recall
  • Publications  -  General safety information provided by the HPRA for publication via 3rd parties e.g. MIMS

The HPRA Drug Safety Newsletter is also published on a regular basis.

Date Title Type
31/10/2006 INHALED CORTICOSTEROIDS 3rd Party Publications
18/10/2006 Extended Recall of Paratabs 500mg Tablets Recall
06/10/2006 Safety Notice Concerning a Chinese Herbal Medicinal Product, Mr. Dragon Capsules Warning
04/10/2006 SAFETY NOTICE Concerning two Homeopathic Medicinal Products for Ophthalmic Use Advisory
27/09/2006 Recall Notice in respect of Paratabs 500 mg Tablets Recall
11/09/2006 Ritalin (methylphenidate hydrochloride) and Ritalin LA (methylphenidate hydrochloride) - Important Safety Information from Novartis as approved by the Irish Medicines Board 3rd Party Publications
03/09/2006 ADVERSE DRUG REACTION 3rd Party Publications
31/08/2006 Bisphosphonates and Osteonecrosis 3rd Party Publications
04/08/2006 Aptivus (tipranavir) - Important Safety Information from Boehringer Ingelheim as approved by the Irish Medicines Board 3rd Party Publications
31/07/2006 Co-Amoxiclav and Hepatobiliary Reactions 3rd Party Publications